The average one-year price target for Cocrystal Pharma (NasdaqCM:COCP) has been revised to $8.16 / share. This is an increase of 14.29% from the prior estimate of $7.14 dated September 27, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $6.06 to a high of $10.50 / share. The average price target represents an increase of 652.07% from the latest reported closing price of $1.08 / share.
What is the Fund Sentiment?
There are 32 funds or institutions reporting positions in Cocrystal Pharma. This is an decrease of 1 owner(s) or 3.03% in the last quarter. Average portfolio weight of all funds dedicated to COCP is 0.00%, an increase of 2.93%. Total shares owned by institutions decreased in the last three months by 7.62% to 755K shares.
What are Other Shareholders Doing?
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 191K shares representing 1.47% ownership of the company. No change in the last quarter.
Renaissance Technologies holds 125K shares representing 0.96% ownership of the company. In its prior filing, the firm reported owning 126K shares , representing a decrease of 0.48%. The firm decreased its portfolio allocation in COCP by 8.21% over the last quarter.
VEXMX - Vanguard Extended Market Index Fund Investor Shares holds 77K shares representing 0.59% ownership of the company. No change in the last quarter.
Geode Capital Management holds 73K shares representing 0.56% ownership of the company. In its prior filing, the firm reported owning 73K shares , representing a decrease of 0.03%. The firm decreased its portfolio allocation in COCP by 6.48% over the last quarter.
Susquehanna International Group, Llp holds 41K shares representing 0.31% ownership of the company. In its prior filing, the firm reported owning 34K shares , representing an increase of 17.08%. The firm increased its portfolio allocation in COCP by 2.99% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
